Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Technology’s Role in Revolutionizing Treatment in Healthcare

Dr. Scott Sigman, host of The Ortho Show, discusses how emerging technologies like AI-powered surgical guidance (CaliberAI/ChatGPT integration) and virtual reality training tools (PrecisionOS) are transforming surgical procedures and patient care. These innovations allow surgeons to rehearse complex interventions in virtual environments and receive real-time AI-driven decision support in the operating room. The segment is part of a broader conversation on the digitization of orthopedic healthcare.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Highway to Health on MarketScale.

By Healthcare ·
Share

Key takeaways

01

CaliberAI is integrating ChatGPT into the operating room to provide real-time AI guidance during surgical interventions.

02

PrecisionOS virtual reality glasses allow surgeons to practice complex surgical procedures in a simulated environment before performing them on patients.

03

Technology adoption in healthcare is accelerating, with AI and VR positioned as key tools for improving surgical precision and patient outcomes.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Dr. Scott Sigman, M.D., host of The Ortho Show, highlights the impending technological advancements in healthcare, emphasizing how it will enhance patient care and revolutionize surgical procedures. Dr. Sigman mentions the integration of ChatGPT in the operating room through CaliberAI, an AI company aiming to guide surgical interventions. Furthermore, Dr. Sigman shares his experience with virtual reality glasses from PrecisionOS, which allows surgeons to practice surgical interventions in a virtual environment.

Technology will enhance patient care and revolutionize surgical procedures.

For additional insights, check out Dr. Sigman's entire conversation with Highway to Health's David Kemp.

Highway to Health

Part of this channel

Highway to Health

Healthcare innovation conversations for executives and technology buyers.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

H
Healthcare

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

H
Healthcare

Host, Highway to Health

DS
Dr. Scott Sigman, M.D.

Host

The Ortho Show

Dr. Scott Sigman is an orthopedic surgeon and host of The Ortho Show, a platform focused on innovations in orthopedic healthcare. He is an advocate for integrating emerging technologies such as AI and virtual reality into surgical practice to improve patient outcomes.

DK
David Kemp

Host

Highway to Health

David Kemp is the host of Highway to Health, a MarketScale show exploring the future of healthcare through conversations with industry innovators and thought leaders.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512